InMode’s Envision platform offers an effective and comfortable non-invasive, multi-modality solution for patients suffering from dry eye disease – especially those exacerbated by allergies, inflammation, or meibomian gland dysfunction (MGD).
Using a combination of bipolar radiofrequency (Forma-I), and intense pulsed light (Lumecca-I), this targeted treatment addresses the root causes of dry eye by stimulating meibum flow, reducing inflammation, and treating conditions including blepharitis and chalazions, thereby improving overall eyelid function.
Envision is designed for use by eye care professionals looking to elevate patient care with evidence-backed technologies. Treatments are fast, with no downtime, making Envision a practical and powerful addition to any modern optometric or ophthalmology practice.
Visit: inmode.com.au
